Peroxisome proliferator-activated receptors and progression of colorectal cancer

PPAR Research

Volumn , Issue , 2008, Pages

  Wang, Dingzhi ^a   DuBois, Raymond N ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL TRANSFORMATION; COLORECTAL CANCER; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 45249099362     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/931074     Document Type: Review

References (80)

1. Solomon S. D.
2. Bresalier R. S.
3. Nussmeier N. A.
4. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 6294 645 650
5. Berger J. P.
6. Michalik L., Desvergne B., Wahli W.
7. Kliewer S. A., Forman B. M., Blumberg B., Differential expression and activation of a family of murine peroxisome proliferator-activated receptors Proceedings of the National Academy of Sciences of the United States of America 1994 91 15 7355 7359
8. Mangelsdorf D. J., Evans R. M., The RXR heterodimers and orphan receptors Cell 1995 83 6 841 850
9. Wang Y.-X., Lee C.-H., Tiep S., Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity Cell 2003 113 2 159 170
10. Tanaka T., Yamamoto J., Iwasaki S., Activation of peroxisome proliferator-activated receptor δ induces fatty acid β -oxidation in skeletal muscle and attenuates metabolic syndrome Proceedings of the National Academy of Sciences of the United States of America 2003 100 26 15924 15929
11. Oliver W. R. Jr., Shenk J. L., Snaith M. R., A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5306 5311
12. Evans R. M.
13. Peters J. M., Cattley R. C., Gonzalez F. J., Role of PPAR α in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 Carcinogenesis 1997 18 11 2029 2033
14. Gupta R. A., Wang D., Katkuri S., Wang H., Dey S. K., DuBois R. N.
15. Wang D., Wang H., Guo Y., Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression Proceedings of the National Academy of Sciences of the United States of America 2006 103 50 19069 19074
16. Grabacka M., Plonka P. M., Urbanska K., Reiss K.
17. Strakova N., Ehrmann J.
18. Grau R., Punzón C., Fresno M., Iñiguez M. A.
19. DuBois R. N.
20. Sarraf P., Mueller E., Smith W. M., Loss-of-function mutations in PPAR γ associated with human colon cancer Molecular Cell 1999 3 6 799 804
21. Slattery M. L.
22. Landi S., Moreno V., Gioia-Patricola L., Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor α, NFKB1, and peroxisome proliferator-activated receptor γ with colorectal cancer Cancer Research 2003 63 13 3560 3566
23. Ikezoe T., Miller C. W., Kawano S., Mutational analysis of the peroxisome proliferator-activated receptor γ gene in human malignancies Cancer Research 2001 61 13 5307 5310
24. Altiok S., Xu M., Spiegelman B. M.
25. Wakino S., Kintscher U., Kim S., Yin F., Hsueh W. A., Law R. E.
26. Heaney A. P.
27. Kitamura S.
28. Qin C., Burghardt R., Smith R., Wormke M., Stewart J., Safe S.
29. Toyota M., Miyazaki Y.
30. Koga H., Sakisaka S., Harada M., Involvement of p21 WAF1/Cip1, p 27 Kip 1, and p 18 INK 4 c in troglitazone-induced cell-cycle arrest in human hepatoma cell lines Hepatology 2001 33 5 1087 1097
31. Gupta R. A., Sarraf P., Brockman J. A., Peroxisome proliferator-activated receptor γ and transforming growth factor- β pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22 Journal of Biological Chemistry 2003 278 9 7431 7438
32. Satoh T., Toyoda M., Hoshino H., Activation of peroxisome proliferator-activated receptor- γ stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells Oncogene 2002 21 14 2171 2180
33. Farrow B., Evers B. M.
34. Chen G. G.
35. Xin X., Yang S., Kowalski J., Gerritsen M. E.
36. Panigrahy D., Singer S., Shen L. Q., PPAR γ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis The Journal of Clinical Investigation 2002 110 7 923 932
37. Liu H., Zang C., Fenner M. H., Possinger K., Elstner E.
38. Shen D., Deng C.
39. Girnun G. D., Smith W. M., Drori S., APC-dependent suppression of colon carcinogenesis by PPAR γ Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13771 13776
40. Inoue H.
41. Quraishi O., Mancini J. A., Riendeau D.
42. Schröder O.
43. Sarraf P., Mueller E., Jones D., Differentiation and reversal of malignant changes in colon cancer through PPAR γ Nature Medicine 1998 4 9 1046 1052
44. Osawa E., Nakajima A.
45. Lefebvre A.-M., Chen I., Desreumaux P., Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J- APC M i n / + mice Nature Medicine 1998 4 9 1053 1057
46. Saez E., Tontonoz P., Nelson M. C., Activators of the nuclear receptor PPAR γ enhance colon polyp formation Nature Medicine 1998 4 9 1058 1061
47. Pino M. V.
48. Yang K., Fan K.-H., Lamprecht S. A., Peroxisome proliferator-activated receptor γ agonist troglitazone induces colon tumors in normal C57BL/6J mice and enhances colonic carcinogenesis in A P C 1638N/+ M l h 1 +/- double mutant mice International Journal of Cancer 2005 116 4 495 499
49. Niho N.
50. Niho N.
51. McAlpine C. A., Barak Y., Matise I., Cormier R. T.
52. Suh N., Wang Y., Williams C. R., A new ligand for the peroxisome proliferator-activated receptor- γ (PPAR- γ), GW7845, inhibits rat mammary carcinogenesis Cancer Research 1999 59 22 5671 5673
53. Saez E., Rosenfeld J., Livolsi A., PPAR γ signaling exacerbates mammary gland tumor development Genes and Development 2004 18 5 528 540
54. Lim H., Gupta R. A., Ma W.-G., Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPAR δ Genes and Development 1999 13 12 1561 1574
55. Lee C.-H., Chawla A., Urbiztondo N., Liao D., Boisvert W. A., Evans R. M.
56. Hao C.-M.
57. Di-Poï N., Tan N. S., Michalik L., Wahli W., Desvergne B.
58. Di-Poï N., Michalik L., Tan N. S., Desvergne B., Wahli W.
59. He T.-C., Chan T. A., Vogelstein B., Kinzler K. W.
60. Gupta R. A., Tan J., Krause W. F., Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer Proceedings of the National Academy of Sciences of the United States of America 2000 97 24 13275 13280
61. Takayama O., Yamamoto H.
62. Vanamala J., Glagolenko A., Yang P., Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPAR δ /PGE2 and elevation of PGE3 Carcinogenesis 2008 29 4 790 796
63. Ouyang N., Williams J. L., Rigas B.
64. Siezen C. L. E., Tijhuis M. J., Kram N. R., Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor δ Pharmacogenetics and Genomics 2006 16 1 43 50
65. Shao J., Sheng H., DuBois R. N., Peroxisome proliferator-activated receptors modulate K- Ras -mediated transformation of intestinal epithelial cells Cancer Research 2002 62 11 3282 3288
66. Wang D., Wang H., Shi Q., Prostaglandin E 2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ Cancer Cell 2004 6 3 285 295
67. Xu L., Han C., Wu T.
68. Xu L., Han C., Lim K., Wu T.
69. Park B. H., Vogelstein B., Kinzler K. W.
70. Barak Y., Liao D., He W., Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer Proceedings of the National Academy of Sciences of the United States of America 2002 99 1 303 308
71. Harman F. S., Nicol C. J., Marin H. E., Ward J. M., Gonzalez F. J., Peters J. M.
72. Reed K. R., Sansom O. J., Hayes A. J., PPAR δ status and Apc-mediated tumourigenesis in the mouse intestine Oncogene 2004 23 55 8992 8996
73. Marin H. E., Peraza M. A., Billin A. N., Ligand activation of peroxisome proliferator-activated receptor β inhibits colon carcinogenesis Cancer Research 2006 66 8 4394 4401
74. Nadra K., Anghel S. I., Joye E., Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor β / δ Molecular and Cellular Biology 2006 26 8 3266 3281
75. Peters J. M.
76. Stephen R. L., Gustafsson M. C. U., Jarvis M., Activation of peroxisome proliferator-activated receptor δ stimulates the proliferation of human breast and prostate cancer cell lines Cancer Research 2004 64 9 3162 3170
77. Glinghammar B.
78. Daikoku T., Tranguch S., Chakrabarty A., Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor- δ signaling in epithelial ovarian cancer Cancer Research 2007 67 11 5285 5292
79. Abdollahi A.
80. Yin Y., Russell R. G., Dettin L. E., Peroxisome proliferator-activated receptor δ and γ agonists differentially alter tumor differentiation and progression during mammary carcinogenesis Cancer Research 2005 65 9 3950 3957